Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it’s a Band-Aid, not a ...

As digital healthcare grows, obtaining medications like Zepbound through online prescriptions has become increasingly popular ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A study from tirzepatide's manufacturer found that the GLP-1 drug could significantly improve heart failure symptoms.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

There are several Ozempic alternatives available today, like Rybelsus, Mounjaro, Wegovy and Zepbound. Other medications may ...

Cramer remains steadfast on Eli Lilly and Company (NYSE:LLY) as per Mad Money’s episode on September 30. Despite there being ...

Today, Lilly competes with Novo Nordisk, and in the future, companies like biotech ... a quick look at why Lilly's drugs and others of the same class are so popular. Mounjaro and Zepbound are ...

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure ...